
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $318.1M | $392.2M | $578.8M | $1B | $1.3B | |
Revenue Growth (YoY) | 12.47% | 23.28% | 47.61% | 76.89% | 28.28% | |
Cost of Revenues | $111.9M | $140.4M | $188.4M | $299.8M | $377.8M | |
Gross Profit | $206.2M | $251.7M | $390.4M | $724.1M | $935.7M | |
Gross Profit Margin | 64.82% | 64.19% | 67.44% | 70.72% | 71.24% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $194.2M | $221.9M | $322.3M | $574.4M | $777.7M | |
Other Inc / (Exp) | -$4.3M | -$1.9M | -$2.1M | -$1.7M | $1.3M | |
Operating Expenses | $194.2M | $221.9M | $322.3M | $574.4M | $777.7M | |
Operating Income | $12M | $29.8M | $68.1M | $149.7M | $158M | |
Net Interest Expenses | $4.1M | $2.4M | $2M | $7M | $13.8M | |
EBT. Incl. Unusual Items | $3.7M | $25.4M | $64.1M | $141M | $145.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.5M | $3.7M | $2.5M | $13.3M | $33.4M | |
Net Income to Company | $6.2M | $21.8M | $61.5M | $127.7M | $112.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $6.2M | $21.8M | $61.5M | $127.7M | $112.1M | |
Basic EPS (Cont. Ops) | $0.13 | $0.43 | $1.17 | $2.33 | $1.99 | |
Diluted EPS (Cont. Ops) | $0.12 | $0.41 | $1.11 | $2.21 | $1.92 | |
Weighted Average Basic Share | $49.4M | $50.9M | $52.5M | $54.7M | $56.2M | |
Weighted Average Diluted Share | $52M | $53.7M | $55.3M | $57.8M | $58.3M | |
EBITDA | $32.1M | $54.6M | $85.3M | $182.6M | $206.2M | |
EBIT | $6.9M | $27.5M | $67.7M | $152.4M | $162.1M | |
Revenue (Reported) | $318.1M | $392.2M | $578.8M | $1B | $1.3B | |
Operating Income (Reported) | $12M | $29.8M | $68.1M | $149.7M | $158M | |
Operating Income (Adjusted) | $6.9M | $27.5M | $67.7M | $152.4M | $162.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $92.7M | $105.1M | $187.4M | $321.1M | $332.6M | |
Revenue Growth (YoY) | 24.04% | 13.45% | 78.21% | 71.41% | 3.58% | |
Cost of Revenues | $34.1M | $37.6M | $58.2M | $93.9M | $95.6M | |
Gross Profit | $58.6M | $67.5M | $129.1M | $227.2M | $237M | |
Gross Profit Margin | 63.24% | 64.2% | 68.92% | 70.75% | 71.26% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $57.8M | $65.3M | $121.1M | $210.2M | $192.7M | |
Other Inc / (Exp) | -$2.7M | -$466K | $320K | -$1.8M | $2.6M | |
Operating Expenses | $57.8M | $65.3M | $121.1M | $210.2M | $192.7M | |
Operating Income | $773K | $2.2M | $8M | $17M | $44.3M | |
Net Interest Expenses | $862K | $529K | $106K | $4M | $2.9M | |
EBT. Incl. Unusual Items | -$2.8M | $1.2M | $8.3M | $11.2M | $44M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.8M | -$383K | -$8M | -$3.3M | $15.8M | |
Net Income to Company | -$24K | $1.6M | $16.2M | $14.5M | $28.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$24K | $1.6M | $16.2M | $14.5M | $28.3M | |
Basic EPS (Cont. Ops) | -$0.00 | $0.03 | $0.31 | $0.26 | $0.50 | |
Diluted EPS (Cont. Ops) | -$0.00 | $0.03 | $0.29 | $0.25 | $0.49 | |
Weighted Average Basic Share | $50M | $51.3M | $53.2M | $55.5M | $56.2M | |
Weighted Average Diluted Share | $52.9M | $53.8M | $56.6M | $58.5M | $58M | |
EBITDA | $3.6M | $8.1M | $11.1M | $29.3M | $62.9M | |
EBIT | -$2.8M | $1.4M | $10M | $19.6M | $49.7M | |
Revenue (Reported) | $92.7M | $105.1M | $187.4M | $321.1M | $332.6M | |
Operating Income (Reported) | $773K | $2.2M | $8M | $17M | $44.3M | |
Operating Income (Adjusted) | -$2.8M | $1.4M | $10M | $19.6M | $49.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $318.1M | $392.2M | $578.8M | $1B | $1.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $111.9M | $140.4M | $188.4M | $299.8M | $377.8M | |
Gross Profit | $206.2M | $251.7M | $390.4M | $724.1M | $935.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $194.2M | $221.9M | $322.3M | $574.4M | $777.7M | |
Other Inc / (Exp) | -$4.3M | -$1.9M | -$2.1M | -$1.7M | $1.3M | |
Operating Expenses | $194.2M | $221.9M | $322.3M | $574.4M | $777.7M | |
Operating Income | $12M | $29.8M | $68.1M | $149.7M | $158M | |
Net Interest Expenses | $4.1M | $2.4M | $2M | $7M | $13.8M | |
EBT. Incl. Unusual Items | $3.7M | $25.4M | $64.1M | $141M | $145.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.5M | $3.7M | $2.5M | $13.3M | $33.4M | |
Net Income to Company | $6.2M | $21.8M | $61.5M | $127.7M | $112.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $6.2M | $21.8M | $61.5M | $127.7M | $112.1M | |
Basic EPS (Cont. Ops) | $0.13 | $0.42 | $1.17 | $2.34 | $2.00 | |
Diluted EPS (Cont. Ops) | $0.12 | $0.41 | $1.11 | $2.22 | $1.93 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $32.1M | $54.6M | $88.2M | $185M | $202.3M | |
EBIT | $6.9M | $27.5M | $70.6M | $154.8M | $158.2M | |
Revenue (Reported) | $318.1M | $392.2M | $578.8M | $1B | $1.3B | |
Operating Income (Reported) | $12M | $29.8M | $68.1M | $149.7M | $158M | |
Operating Income (Adjusted) | $6.9M | $27.5M | $70.6M | $154.8M | $158.2M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $392.2M | $578.8M | $1B | $1.3B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $140.4M | $188.4M | $299.8M | $377.8M | -- | |
Gross Profit | $251.7M | $390.4M | $724.1M | $935.7M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $221.9M | $322.3M | $574.4M | $777.7M | -- | |
Other Inc / (Exp) | -$1.9M | -$2.1M | -$1.7M | $1.3M | -- | |
Operating Expenses | $221.9M | $322.3M | $574.4M | $777.7M | -- | |
Operating Income | $29.8M | $68.1M | $149.7M | $158M | -- | |
Net Interest Expenses | $2.4M | $2M | $8M | $13.8M | -- | |
EBT. Incl. Unusual Items | $25.4M | $64.1M | $141M | $145.5M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.7M | $2.5M | $13.3M | $33.4M | -- | |
Net Income to Company | $21.8M | $61.5M | $127.7M | $112.1M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $21.8M | $61.5M | $127.7M | $112.1M | -- | |
Basic EPS (Cont. Ops) | $0.42 | $1.17 | $2.34 | $2.00 | -- | |
Diluted EPS (Cont. Ops) | $0.41 | $1.11 | $2.22 | $1.93 | -- | |
Weighted Average Basic Share | $203.8M | $209.9M | $219M | $224.8M | -- | |
Weighted Average Diluted Share | $214.6M | $221.3M | $231.1M | $233.4M | -- | |
EBITDA | $54.6M | $88.2M | $185M | $202.3M | -- | |
EBIT | $27.5M | $70.6M | $154.8M | $158.2M | -- | |
Revenue (Reported) | $392.2M | $578.8M | $1B | $1.3B | -- | |
Operating Income (Reported) | $29.8M | $68.1M | $149.7M | $158M | -- | |
Operating Income (Adjusted) | $27.5M | $70.6M | $154.8M | $158.2M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $57.8M | $43.4M | $120.8M | $108.2M | $148.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $40.2M | $45.6M | $67.9M | $123.8M | $126M | |
Inventory | $56.8M | $84.5M | $81.3M | $191.5M | $187.2M | |
Prepaid Expenses | $15.4M | -- | -- | -- | -- | |
Other Current Assets | -- | $19.6M | $33.3M | $53.6M | $78.7M | |
Total Current Assets | $170.1M | $193M | $303.3M | $477.1M | $540.6M | |
Property Plant And Equipment | $13.8M | $10.6M | $7.9M | $14M | $28.8M | |
Long-Term Investments | $2.9M | $2.9M | -- | -- | -- | |
Goodwill | $171.6M | $171.6M | $171.6M | $340.6M | $340.6M | |
Other Intangibles | $94.3M | $86.2M | $78M | $225.1M | $207.7M | |
Other Long-Term Assets | $34.7M | $30.4M | $34.7M | $72.5M | $130.5M | |
Total Assets | $487.4M | $494.6M | $595.6M | $1.1B | $1.2B | |
Accounts Payable | $15.7M | $19.2M | $31.4M | $81.1M | $72.2M | |
Accrued Expenses | $21.3M | $19.9M | $47.8M | $83.5M | $61.2M | |
Current Portion Of Long-Term Debt | $16.3M | $5.8M | $5.6M | $100.3M | -- | |
Current Portion Of Capital Lease Obligations | $4.3M | $4.4M | $4.5M | $7M | $7.6M | |
Other Current Liabilities | $5M | $2M | $2.7M | $3.9M | $2.2M | |
Total Current Liabilities | $73.3M | $65M | $108M | $299.1M | $177.1M | |
Long-Term Debt | $110.3M | $91.1M | $60.9M | $161.8M | $256.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $217.7M | $182.2M | $184.6M | $486.7M | $487.3M | |
Common Stock | $504K | $515K | $535K | $555K | $556K | |
Other Common Equity Adj | -- | -- | -- | -$50K | $521K | |
Common Equity | $269.6M | $312.4M | $411M | $642.6M | $760.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $269.6M | $312.4M | $411M | $642.6M | $760.9M | |
Total Liabilities and Equity | $487.4M | $494.6M | $595.6M | $1.1B | $1.2B | |
Cash and Short Terms | $57.8M | $43.4M | $120.8M | $108.2M | $148.7M | |
Total Debt | $126.5M | $96.9M | $66.5M | $262.1M | $256.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $57.8M | $43.4M | $120.8M | $108.2M | $148.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $40.2M | $45.6M | $67.9M | $123.8M | $126M | |
Inventory | $56.8M | $84.5M | $81.3M | $191.5M | $187.2M | |
Prepaid Expenses | $15.4M | -- | -- | -- | -- | |
Other Current Assets | -- | $19.6M | $33.3M | $53.6M | $78.7M | |
Total Current Assets | $170.1M | $193M | $303.3M | $477.1M | $540.6M | |
Property Plant And Equipment | $13.8M | $10.6M | $7.9M | $14M | $28.8M | |
Long-Term Investments | $2.9M | $2.9M | -- | -- | -- | |
Goodwill | $171.6M | $171.6M | $171.6M | $340.6M | $340.6M | |
Other Intangibles | $94.3M | $86.2M | $78M | $225.1M | $207.7M | |
Other Long-Term Assets | $34.7M | $30.4M | $34.7M | $72.5M | $130.5M | |
Total Assets | $487.4M | $494.6M | $595.6M | $1.1B | $1.2B | |
Accounts Payable | $15.7M | $19.2M | $31.4M | $81.1M | $72.2M | |
Accrued Expenses | $21.3M | $19.9M | $47.8M | $83.5M | $61.2M | |
Current Portion Of Long-Term Debt | $16.3M | $5.8M | $5.6M | $100.3M | -- | |
Current Portion Of Capital Lease Obligations | $4.3M | $4.4M | $4.5M | $7M | $7.6M | |
Other Current Liabilities | $5M | $2M | $2.7M | $3.9M | $2.2M | |
Total Current Liabilities | $73.3M | $65M | $108M | $299.1M | $177.1M | |
Long-Term Debt | $110.3M | $91.1M | $60.9M | $161.8M | $256.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $217.7M | $182.2M | $184.6M | $486.7M | $487.3M | |
Common Stock | $504K | $515K | $535K | $555K | $556K | |
Other Common Equity Adj | -- | -- | -- | -$50K | $521K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $269.6M | $312.4M | $411M | $642.6M | $760.9M | |
Total Liabilities and Equity | $487.4M | $494.6M | $595.6M | $1.1B | $1.2B | |
Cash and Short Terms | $57.8M | $43.4M | $120.8M | $108.2M | $148.7M | |
Total Debt | $126.5M | $96.9M | $66.5M | $262.1M | $256.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $6.2M | $21.8M | $61.5M | $127.7M | $112.1M | |
Depreciation & Amoritzation | $25.2M | $27.1M | $17.6M | $30.2M | $44.1M | |
Stock-Based Compensation | $19.7M | $19.6M | $29.1M | $40.6M | $71.8M | |
Change in Accounts Receivable | -$10.5M | -$5.6M | -$22.4M | -$49.6M | -$2.7M | |
Change in Inventories | -$10.9M | -$27.7M | $3.2M | -$93.9M | $4.9M | |
Cash From Operations | $29.5M | $19.5M | $101.9M | $71.2M | $133.8M | |
Capital Expenditures | $6.5M | $4.8M | $1.7M | $8.7M | $18.5M | |
Cash Acquisitions | -- | -- | -- | -$275M | -- | |
Cash From Investing | -$6.5M | -$4.8M | -$1.7M | -$284.7M | -$19.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $20M | $52.1M | -- | $204.5M | $256.7M | |
Long-Term Debt Repaid | -$31.8M | -$81M | -$30M | -$7.9M | -$262.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$67.1M | |
Other Financing Activities | -$1.1M | -$1.8M | -$788K | -$1.2M | -$2.1M | |
Cash From Financing | -$11.4M | -$29.1M | -$22.7M | $200.9M | -$74.4M | |
Beginning Cash (CF) | $46.2M | $57.8M | $43.4M | $120.8M | $108.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.6M | -$14.4M | $77.4M | -$12.6M | $40.3M | |
Ending Cash (CF) | $57.8M | $43.4M | $120.8M | $108.2M | $148.7M | |
Levered Free Cash Flow | $23M | $14.7M | $100.2M | $62.5M | $115.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$24K | $1.6M | $16.2M | $14.5M | $28.3M | |
Depreciation & Amoritzation | $6.4M | $6.8M | $1.1M | $9.7M | $13.2M | |
Stock-Based Compensation | $4.6M | $5M | $7.3M | $11.2M | $14.8M | |
Change in Accounts Receivable | $4.3M | $1.6M | -$1.8M | -$3.7M | $62.3M | |
Change in Inventories | $11.4M | $735K | -$74K | $13M | $28.5M | |
Cash From Operations | $27.5M | $11.7M | $32.9M | $37M | $136.1M | |
Capital Expenditures | $2.5M | $222K | $76K | $2.7M | $11.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.5M | -$222K | -$76K | -$3.7M | -$11.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $256.7M | |
Long-Term Debt Repaid | -$3.1M | -$1.3M | -$1.3M | -$2.7M | -$254.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$50M | |
Other Financing Activities | -$208K | -$192K | -$200K | -$87K | -$2.1M | |
Cash From Financing | -$2.7M | -$1M | $951K | -$106K | -$50.2M | |
Beginning Cash (CF) | $35.4M | $32.9M | $87M | $75M | $73.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | $22K | $276K | |
Additions / Reductions | $22.3M | $10.5M | $33.8M | $33.2M | $74.6M | |
Ending Cash (CF) | $57.8M | $43.4M | $120.8M | $108.2M | $148.7M | |
Levered Free Cash Flow | $25M | $11.5M | $32.8M | $34.3M | $125M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $6.2M | $21.8M | $61.5M | $127.7M | $112.1M | |
Depreciation & Amoritzation | $25.2M | $27.1M | $17.6M | $30.2M | $44.1M | |
Stock-Based Compensation | $19.7M | $19.6M | $29.1M | $40.6M | $71.8M | |
Change in Accounts Receivable | -$10.5M | -$5.6M | -$22.4M | -$49.6M | -$2.7M | |
Change in Inventories | -$10.9M | -$27.7M | $3.2M | -$93.9M | $4.9M | |
Cash From Operations | $29.5M | $19.5M | $101.9M | $71.2M | $133.8M | |
Capital Expenditures | $6.5M | $4.8M | $1.7M | $8.7M | $18.5M | |
Cash Acquisitions | -- | -- | -- | -$275M | -- | |
Cash From Investing | -$6.5M | -$4.8M | -$1.7M | -$284.7M | -$19.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $20M | $52.1M | -- | -- | -- | |
Long-Term Debt Repaid | -$31.8M | -$81M | -$30M | -$7.9M | -$262.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.1M | -$1.8M | -$788K | -$1.2M | -$2.1M | |
Cash From Financing | -$11.4M | -$29.1M | -$22.7M | $200.9M | -$74.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.6M | -$14.4M | $77.4M | -$12.6M | $40.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $23M | $14.7M | $100.2M | $62.5M | $115.3M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $21.8M | $61.5M | $127.7M | $112.1M | -- | |
Depreciation & Amoritzation | $27.1M | $17.6M | $30.2M | $44.1M | -- | |
Stock-Based Compensation | $19.6M | $29.1M | $40.6M | $71.8M | -- | |
Change in Accounts Receivable | -$5.6M | -$22.4M | -$49.6M | -$2.7M | -- | |
Change in Inventories | -$27.7M | $3.2M | -$93.9M | $4.9M | -- | |
Cash From Operations | $19.5M | $101.9M | $71.2M | $133.8M | -- | |
Capital Expenditures | $4.8M | $1.7M | $8.7M | $18.5M | -- | |
Cash Acquisitions | -- | -- | -$275M | -- | -- | |
Cash From Investing | -$4.8M | -$1.7M | -$284.7M | -$19.1M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $52.1M | -- | $204.5M | $256.7M | -- | |
Long-Term Debt Repaid | -$81M | -$30M | -$7.9M | -$262.9M | -- | |
Repurchase of Common Stock | -- | -- | -- | -$67.1M | -- | |
Other Financing Activities | -$1.8M | -$788K | -$1.2M | -$2.1M | -- | |
Cash From Financing | -$29.1M | -$22.7M | $200.9M | -$74.4M | -- | |
Beginning Cash (CF) | $195.8M | $287.9M | $506M | $387.8M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -$34K | $215K | -- | |
Additions / Reductions | -$14.4M | $77.4M | -$12.6M | $40.3M | -- | |
Ending Cash (CF) | $181.3M | $365.4M | $493.5M | $428.3M | -- | |
Levered Free Cash Flow | $14.7M | $100.2M | $62.5M | $115.3M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.